Buy Stocks Easy | About Us
May 8, 2021
Buy Stocks Easy | Online Stocks

DARE


Buy Dare Bioscience, Inc. Stock (symbol: DARE) Easy Online

Company Name: Dare Bioscience, Inc.

Symbol: DARE

Sector: Health Care

Industry: Major Pharmaceuticals

IPO:

DARE Current Share Price

Today's DARE ( Dare Bioscience, Inc. ) opening price: $0.8543

Yesterday's DARE ( Dare Bioscience, Inc. ) closing price: $0.8700

Dare Bioscience, Inc. Stock ( symbol: DARE ) Price Chart since IPO ():

12 Months Dare Bioscience, Inc. Stock ( symbol: DARE ) Price Chart

Popular Questions about Dare Bioscience, Inc. Public Stock ( DARE )

A: Dare Bioscience, Inc. stock symbol (also called stock or share ticker) is DARE

A: Dare Bioscience, Inc. IPO (Initial Public Offering) took place on

A: Dare Bioscience, Inc.'s stock (DARE symbol) price at ther IPO (initial Public Offering) was $0.8543

Q: Is DARE stock worth buying at the moment?

A: The DARE stock performance since 2019 are rather disappointing. If you had bought 1 share of Dare Bioscience, Inc. stock (symbol: DARE) at the beginning of 2019, at the opening share price of $, you would be left with exactly $0.8543 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Dare Bioscience, Inc. Stock Easy Online

Dare Bioscience, Inc. Stock Ticker Price Chart since IPO:





Dare Bioscience, Inc. Stock Price Yesterday



 


Dare Bioscience, Inc. Stock Price – Last Week




 


Dare Bioscience, Inc. Stock Price – Last Month




 


Dare Bioscience, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/11/1959193/0/en/Dar%C3%A9-Bioscience-Announces-Alignment-with-the-FDA-on-Phase-2b-Study-Design-and-Novel-Primary-Endpoint-PRO-Instruments-to-Support-the-Continued-Clinical-Development-of-Sildenafil-Cre.html
                            

                                
Daré Bioscience Announces Alignment with the FDA on Phase 2b Study Design and Novel Primary Endpoint PRO Instruments to Support the Continued Clinical Development of Sildenafil Cream, 3.6%, a Potential Therapy for Female Sexual Arousal Disorder

                                
                                
Sildenafil Cream, 3.6% has the Potential to Be the First FDA-Approv...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/21/1950720/0/en/Dar%C3%A9-Bioscience-Closes-Previously-Announced-Acquisition-of-Microchips-Biotech-with-a-First-in-Class-Wireless-User-Controlled-Drug-Delivery-Platform.html
                            

                                
Daré Bioscience Closes Previously Announced Acquisition of Microchips Biotech with a First-in-Class Wireless, User-Controlled Drug Delivery Platform

                                
                                
Contraceptive Program Supported by up to $20.5 Million in Grant Fun...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4307190-dare-bioscience-inc-dare-ceo-sabrina-martucci-johnson-q3-2019-results-earnings-call
                            

                                
Daré Bioscience, Inc. (DARE) CEO Sabrina Martucci Johnson on Q3 2019 Results - Earnings Call Transcript

                                
                                
Daré Bioscience, Inc. (DARE) CEO Sabrina Martucci Johnson on Q3 201...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/11/1944689/0/en/Dar%C3%A9-Bioscience-Enters-into-Agreement-to-Acquire-Microchips-Biotech-Including-Its-First-in-Class-Wireless-User-Controlled-Drug-Delivery-Platform.html
                            

                                
Daré Bioscience Enters into Agreement to Acquire Microchips Biotech Including Its First-in-Class Wireless, User-Controlled Drug Delivery Platform

                                
                                
Contraceptive Program Supported by up to $20.5 Million in Grant Fun...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/28/1936149/0/en/Dar%C3%A9-Bioscience-and-Strategic-Science-Technologies-Announce-Presentation-of-Positive-Findings-from-Thermography-Clinical-Study-of-Sildenafil-Cream-3-6-in-Healthy-Women-at-the-Sexua.html
                            

                                
Daré Bioscience and Strategic Science & Technologies Announce Presentation of Positive Findings from Thermography Clinical Study of Sildenafil Cream, 3.6 % in Healthy Women at the Sexual Medicine Society of North America Conference

                                
                                
Sildenafil Cream, 3.6% produced statistically significant and clini...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/14/1929117/0/en/Dar%C3%A9-Bioscience-to-Participate-in-Two-Upcoming-Investor-Conferences.html
                            

                                
Daré Bioscience to Participate in Two Upcoming Investor Conferences

                                
                                
SAN DIEGO, Oct.  14, 2019  (GLOBE NEWSWIRE) -- Daré Bioscience, Inc...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/10/1927985/0/en/Dar%C3%A9-Bioscience-Announces-a-Poster-Presentation-on-a-Pharmacokinetic-Study-of-DARE-FRT1-in-Development-for-Sustained-Release-Progesterone-Therapy-for-Pregnancy-Maintenance-at-the-A.html
                            

                                
Daré Bioscience Announces a Poster Presentation on a Pharmacokinetic Study of DARE-FRT1, in Development for Sustained-Release Progesterone Therapy for Pregnancy Maintenance, at the American Society for Reproductive Medicine 2019 Scientific Congress & Expo

                                
                                
SAN DIEGO, Oct.  10, 2019  (GLOBE NEWSWIRE) -- Daré Bioscience, Inc...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/07/1925792/0/en/Dar%C3%A9-Bioscience-to-Present-an-Overview-on-its-Intravaginal-Ring-IVR-Technology-in-Development-for-Sustained-Release-Hormone-Therapy-and-Pregnancy-Maintenance-at-the-9th-Annual-Part.html
                            

                                
Daré Bioscience to Present an Overview on its Intravaginal Ring (IVR) Technology in Development for Sustained-Release Hormone Therapy and Pregnancy Maintenance at the 9th Annual Partnership Opportunities in Drug Delivery Conference

                                
                                
SAN DIEGO, Oct.  07, 2019  (GLOBE NEWSWIRE) -- Daré Bioscience, Inc...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4285730-dare-bioscience-inc-dare-ceo-sabrina-martucci-johnson-q2-2019-results-earnings-call
                            

                                
Daré Bioscience, Inc. (DARE) CEO Sabrina Martucci Johnson on Q2 2019 Results - Earnings Call Transcript

                                
                                
Daré Bioscience, Inc. (DARE) CEO Sabrina Martucci Johnson on Q2 201...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4264042-dare-bioscience-inc-dare-ceo-sabrina-martucci-johnson-q1-2019-results-earnings-call?source=feed_sector_transcripts
                            

                                
Daré Bioscience, Inc. (DARE) CEO Sabrina Martucci Johnson on Q1 2019 Results - Earnings Call Transcript

                                
                                
Daré Bioscience, Inc. (DARE) CEO Sabrina Martucci Johnson on Q1 201...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.